Related Experiment Videos
Lidocaine protein binding in preeclampsia.
European Journal of Clinical Pharmacology
|January 1, 1987
Summary
Preeclampsia minimally impacts lidocaine binding to serum proteins, with no significant changes in free fraction or binding ratio. However, altered interactions with alpha-1-acid glycoprotein (AAG) were observed.
Area of Science:
- Pharmacology
- Obstetrics
- Clinical Chemistry
Background:
- Preeclampsia is a pregnancy complication affecting maternal physiology.
- Lidocaine is a commonly used local anesthetic.
- Understanding drug binding to serum proteins is crucial for therapeutic efficacy.
Purpose of the Study:
- To investigate the effect of severe preeclampsia on lidocaine binding to serum proteins.
- To compare lidocaine free fraction, binding ratio, and alpha-1-acid glycoprotein (AAG) levels in preeclamptic and normal parturients.
Main Methods:
- Studied 25 term parturients with severe preeclampsia and 21 normal parturients.
- Measured lidocaine free fraction and binding ratio.
- Assessed serum AAG concentrations.
Main Results:
- No statistically significant differences in mean lidocaine free fraction, binding ratio, or serum AAG levels between groups.
- Strong correlation between binding ratio and AAG concentration in both control (r=0.91) and preeclamptic (r=0.85) patients.
- Statistically significant difference in the slopes of the lines relating binding ratio to AAG concentration, suggesting altered binding interactions.
Conclusions:
- Preeclampsia has minimal effect on overall serum AAG concentrations and lidocaine binding ratio.
- Preeclampsia may alter the specific interaction of lidocaine with binding sites on AAG without significantly changing the lidocaine free fraction.